Warfarin/antibiotic interactions
Pharmacy E-Bulletin from 14 Nov 11
A joint initiative of the Patient Services Section and the Drug and Therapeutics Information Service of the Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia. The RGH Pharmacy E-Bulletin is distributed in electronic format on a weekly basis, and aims to present concise, factual information on issues of current interest in therapeutics, drug safety and cost-effective use of medications.
Editor: Assoc. Prof. Chris Alderman, University of South Australia - Director of Pharmacy, RGH
Β© Pharmacy Department, Repatriation General Hospital, Daw Park, South Australia 5041
While alternative oral anticoagulant drugs such as dabigatran have recently been developed, warfarin is currently still the most commonly used and only PBS-listed oral anticoagulant in Australia for the prevention and treatment of thromboembolism in patients with mechanical heart valves, atrial fibrillation and deep vein thrombosis or pulmonary embolus.
The above snippet is the first part of the Pharmacy E-Bulletin published on 14 Nov 11
CLICK HERE to download the RGH Pharmacy E-Bulletin from 14 Nov 11
